このアイテムのアクセス数: 37
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.mmcr.2024.100689.pdf | 3.07 MB | Adobe PDF | 見る/開く |
タイトル: | Uncommon concurrent pulmonary infections: Aspergillus fumigatus and Lomentospora prolificans in an Anti-MDA5 antibody-positive dermatomyositis patient |
著者: | Fukumura, Maaya Hiwa, Ryosuke Yukawa, Satomi Tsuchido, Yasuhiro ![]() ![]() ![]() Yoshifuji, Hajime Morinobu, Akio |
著者名の別形: | 福村, 麻綾 日和, 良介 湯川, 理己 土戸, 康弘 吉藤, 元 森信, 暁雄 |
キーワード: | Anti-MDA5 antibody-positive dermatomyositis Rapidly progressive interstitial lung disease Aspergillus fumigatus Lomentospora prolificans |
発行日: | Mar-2025 |
出版者: | Elsevier BV International Society for Human and Animal Mycology |
誌名: | Medical Mycology Case Reports |
巻: | 47 |
論文番号: | 100689 |
抄録: | A 59-year-old female with anti-MDA5 antibody-positive dermatomyositis was treated with prednisolone, tacrolimus, cyclophosphamide, tofacitinib, and plasma exchange. Five months post-treatment, elevated β-D-glucan levels and a pulmonary shadow on CT were noted. Aspergillus fumigatus was identified, leading to voriconazole initiation. A new pulmonary cavity lesion later revealed Lomentospora prolificans. Considering voriconazole resistance, terbinafine was added, resulting in clinical improvement. Vigilant infection monitoring is crucial during anti-MDA5 antibody-positive dermatomyositis treatment. |
著作権等: | © 2024 The Authors. Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology. This is an open access article under the CC BY license. |
URI: | http://hdl.handle.net/2433/291656 |
DOI(出版社版): | 10.1016/j.mmcr.2024.100689 |
PubMed ID: | 39760058 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス